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Abstract 
 
TESTOSTERONE AND VITAMIN D CONCENTRATIONS IN MILITARY PERSONNEL 
FOLLOWING TRAUMATIC BRAIN INJURY 
 
Kelsey C. Tillotson 
BS, Appalachian State University 
MS, Appalachian State University 
 
 
Chairperson: Dr. Laurel M. Wentz 
 
 
 Traumatic Brain injury (TBI) contributes to a large portion of injuries sustained by 
service members and can cause neuroendocrine dysfunction by damaging the pituitary or 
hypothalamus during injury. Hypopituitarism with gonadotropin deficiency is one of the 
most prevalent types of neuroendocrine dysfunction following TBI and has been predicted to 
cause long-term secondary hypogonadism in up to 16% of individuals with a TBI diagnosis. 
Although it’s a different mechanism from neuroendocrine disorders, vitamin D deficiency 
may be associated with TBI sequelae. A few civilian studies have investigated vitamin D 
status post-TBI and high rates of vitamin D deficiency were prevalent. It is unclear if TBI 
causes low vitamin D, but if vitamin D is low prior to TBI it may exacerbate injury. The 
purpose of this study was to investigate testosterone and vitamin D status in active duty and 
retired service members, with and without a history of traumatic brain injury, and the 
frequency of testosterone replacement therapy prescriptions to identify targets for therapeutic 
treatments to improve long-term recovery. This retrospective de-identified medical review 
analyzed hormone assessments ordered for 4,285 active duty and veteran military personnel 
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at Womack Army Medical Center, Fort Bragg, NC from 2016-2018. Overall, 343 (8%) of 
service members had a medically diagnosed TBI. In all men, 19% were deficient in 
testosterone (< 270 ng/dl), and 10% had a testosterone prescription. Active duty men with 
history of TBI had lower testosterone compared to active duty men with no documented head 
injury (431 ± 162 vs 452 ± 170 ng/dl, p = 0.04), but there was no significant difference in 
veteran men. More than one-third (38%) of all service members were insufficient in vitamin 
D (< 30 ng/ml). Service members with a history of TBI had slightly higher vitamin D 
concentrations compared to those with no prior head injury, but the difference was minimal 
(2 ng/ml) and of little clinical significance. Overall there was a weak positive correlation 
between testosterone and vitamin D concentrations in men but not in women. Although our 
8% diagnosis rate of TBI was lower than previous studies, we found slightly lower 
testosterone concentrations in active duty men with documented TBI. Correlations between 
testosterone and vitamin D concentrations were weak. However, our overall dataset shows a 
high prevalence of vitamin D insufficiency in both active duty and retired service members 
independent of TBI, further supporting that vitamin D status should be assessed regularly in 
service members. 
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Foreword 
 
Chapter 2 of this thesis will be submitted to The Journal of Military and Veterans’ 
Health, a peer-reviewed journal published by the Australasian Military Medicine Association 
and overseen by the JMVH Editorial Board; it has been formatted according to the style 
guide for that journal.  
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Chapter 1: Introduction 
Problem 
Traumatic brain injury (TBI) causes long-term consequences including degenerative 
diseases, psychiatric disorders and cognitive, behavioral, and physical defects that may 
prevent military personnel from performing to their greatest potential and negatively impact 
long-term health.1,2 Since 2000, 413,858 service members have been diagnosed with at least 
one TBI, 83% of which were classified as mild TBI (mTBI).3 Neuroendocrine dysfunction is 
a common consequence of TBI, as nearly half of all cases result in symptoms of 
neuroendocrine dysfunction.4 Neuroendocrine dysfunction is the term for a variety of 
hormone imbalances directly related to the hypothalamus, pituitary and their axes and is 
characterized by fatigue, anxiety, irritability, depression, insomnia, infertility, cognitive 
deficits, and weight changes.5,6 Pituitary dysfunction or hypopituitarism, is a biochemical 
deficiency in one or more endocrine axes by either an inadequate supply of hypothalamic-
releasing hormones or the gland’s inability to produce hormones.7 Hypopituitarism with 
gonadotropin deficiency is one of the most prevalent types of neuroendocrine dysfunction 
following TBI and has been predicted to cause long-term secondary hypogonadism in up to 
16% of individuals with a TBI diagnosis.8,9 Secondary hypogonadism is caused by damage to 
the hypothalamic-pituitary-gonadal axis and is characterized by low testosterone with low to 
normal follicle stimulating hormone and luteinizing hormone levels in men.10 
Although it’s a different mechanism from neuroendocrine disorders, vitamin D 
deficiency may be associated with TBI sequelae. Vitamin D is a secosteroid hormone that 
regulates the expression of over 1000 genes with the vitamin D receptor (VDR).11 Five 
studies have found vitamin D deficiency to be prevalent in patients following a TBI.12-16 
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However, numerous studies have shown high rates of vitamin D deficiency and insufficiency 
in military personnel and recruits overall.17-23 Wentz et al.23 found that 56% of service 
members who had vitamin D assessed at Womack Army Medical Center, Fort Bragg, NC to 
be deficient or insufficient in vitamin D (25-hydroxyvitamin D < 30 ng/ml). Thus, it remains 
unclear if low vitamin D exacerbates injury or TBI causes low vitamin D.23 
TBI contributes to a large portion of injuries sustained by service members and may 
cause lasting effects such as sleep disorders, memory deficits, impaired judgment, 
aggression, and impulsivity.6 TBI, neuroendocrine dysfunction, and vitamin D deficiency 
have many overlapping symptoms, making it difficult to distinguish hormonal abnormalities 
from post-concussive symptoms.6,14 Post-concussive symptoms that parallel neuroendocrine 
dysfunction symptoms include fatigue, poor memory, anxiety, emotional lability, depression, 
weight gain or loss, and attention and concentration problems.6 Low vitamin D status has 
been correlated with impaired cognitive function and depressive symptoms.14 
Scientific Rationale  
TBI has been shown to cause pituitary dysfunction, which manifests in low 
testosterone, and may have an effect on vitamin D status.4,14 Pituitary dysfunction is caused 
by direct mechanical trauma, posttraumatic hypoxia, or shearing axonal injury to the central 
nervous system mechanisms of the hypothalamic-pituitary-target organ axes.8,24 This injury 
affects hormone concentrations from either an inadequate supply of hypothalamic-releasing 
hormones or the gland’s inability to produce hormones.7 Testosterone production may be 
reduced post-TBI as a result of inflammatory cascade cytokines suppressing Leydig cell 
function in the testes, which in turn leads to hypothalamic-pituitary-gonadal axis dysfunction 
and suppresses testosterone.24 Although controversial, the Endocrine Society recommends 
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testosterone replacement therapy for men with consistent symptoms and signs of androgen 
deficiency with low serum testosterone concentrations.25 One study has investigated the 
effects of testosterone therapy after TBI but results have not been published to date.26 
However, androgen prescriptions recorded in military facilities increased from 19,494 in 
2007 to 45,270 in 2011.27 In 2017, 4.7 per 1,000 active service men underwent testosterone 
replacement therapy.28 
Some evidence establishes an association between testosterone and vitamin D 
concentrations. For example, Nimptsch et al.29 found that testosterone was positively 
correlated with vitamin D concentrations in older civilian men, possibly due to the expression 
of the vitamin D receptor and metabolizing enzymes in the Leydig cells of the testes. These 
data suggest that vitamin D has a supporting role in regulating testosterone production.30 
Furthermore, vitamin D may be important for attenuating inflammation post-injury, as 
several animal studies have shown neuroinflammation and cell death reduction and improved 
memory when vitamin D is added to progesterone treatments after TBI.31-35 There are a few 
mechanisms to explain low vitamin D status following TBI. The vitamin D receptor (VDR) 
is located in neuronal and glial cells in the brain, suggesting vitamin D may be a possible 
neurosteroid through autocrine and paracrine function.11 If vitamin D is in fact a 
neurosteroid, then it can modulate neuronal excitability and become a therapeutic approach 
for TBI outcomes.36 Vitamin D’s neuroprotective role following TBI has been explored in 
several studies, most of which have used animal models. Cui et al.31 found vitamin D to be 
neuroprotective by its regulation of cell death following TBI in rats. Cekic et al.37 suggested 
that vitamin D deficiency could exacerbate brain inflammation from TBI and hinder the 
effectiveness of progesterone treatment. Cekic & Stein38 found increased inflammation after 
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TBI in vitamin D deficient rats and suggested that vitamin D deficiency produces a higher 
baseline level of inflammation, increased immune-inflammatory response, and a more severe 
secondary injury progression after TBI. Lee et al.15 found vitamin D supplementation 
increased long-term performance and cognitive outcomes in mild-to-moderate vitamin D 
deficient patients, while another study found patients with vitamin D deficiency on admission 
to the neurological critical care unit had worse 3-month Glasgow Outcome Scores than 
vitamin sufficient patients.32 Another mechanism contributing to reduced vitamin D in TBI 
patients is reduced sun exposure due to hospitalization, time off work, and depression.16  
Significance  
Numerous studies have shown a decrease in testosterone and vitamin D 
concentrations following TBI in civilians.12-16,39-45 These studies have investigated mild, 
moderate, and severe TBI in relation to hypopituitarism and testosterone concentrations. 
Studies have shown severe hypopituitarism in all severities of TBI with hypogonadism being 
common. However, low testosterone results have varied based on injury severity.9 Four 
studies have investigated testosterone status in military personnel following mild, moderate, 
and severe blast related TBI.  These studies found low testosterone with injury with one 
study observed a significant decrease in testosterone 3 years after injury compared to 
controls.4,46-48 These studies did not measure vitamin D status in those with TBI or altered 
testosterone or investigated rates of testosterone replacement therapy after TBI. Furthermore, 
studies investigating both male and female as well as active duty and veteran service 
members together are lacking. Five studies to date have investigated vitamin D status post-
TBI. Jamall et al.14 focused on moderate to severe TBI, while other studies have investigated 
mild, moderate, and severe TBI.12,13,15,16 Jamall et al.14 found nearly half of their patients 
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were deficient in vitamin D after all severities of TBI, while Toman et al.16 found the lowest 
vitamin D concentrations in the most severe cases of TBI. Lee et al.15 found 95% of patients 
were vitamin D deficient after TBI, showing that patients with mild-to-moderate TBI and 
inadequate vitamin D status who received vitamin D supplementation showed a greater 
degree of recovery after 3 months compared to those who were not supplemented. Daradkeh 
et al.12 and Dubiel et al.13 found 24% and 26% of TBI participants were deficient and an 
additional 67% and 36% of participants were insufficient, respectively. Neither study 
commented on differences between severities. Cut-offs for vitamin D deficiency varied 
between studies with < 10, 14, 16, and 30 ng/ml considered deficient. According to the 
Institute of Medicine, vitamin D deficiency is defined as serum 25 hydroxyvitamin D < 20 
ng/ml.49 The Endocrine Society Guidelines defines vitamin D insufficiency as serum 25 
hydroxyvitamin D between 21-29 ng/ml.50  
Research assessing testosterone and vitamin D status in military personnel following 
TBI is lacking, despite the evidence that these hormone deficiencies may exacerbate post-
concussive symptoms. Furthermore, no research to date has examined testosterone 
replacement therapy following TBI. Therefore, the purpose of this study was to investigate 
testosterone and vitamin D concentrations in service members with and without a history of 
TBI to identify differences in these hormones as well as rates of testosterone replacement 
therapy. Incidence of post-TBI hypogonadism and vitamin D deficiency in military personnel 
helps to identify targets for therapeutic treatments to improve long-term recovery. 
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Goals 
 
This retrospective study aims to investigate testosterone and vitamin D status in 
active duty and retired service members, with and without a history of traumatic brain injury, 
and the frequency of testosterone replacement therapy prescriptions.  
Aim 1: We will investigate if service members with a history of TBI have lower testosterone 
concentrations than service members without prior injury.  
Aim 2: We will investigate if service members with a history of TBI have lower vitamin D 
concentrations than service members without prior injury. 
Aim 3: We will investigate significant correlations between testosterone and vitamin D 
concentrations with service members with and without a history of TBI.  
Aim 4: We will investigate if service members with a history of TBI are more likely to have 
a testosterone replacement therapy prescription than service members without prior injury.  
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Abstract:  
Background: Traumatic brain injury (TBI) has been shown to cause pituitary dysfunction, 
manifesting in low testosterone concentrations, and some research has shown vitamin D 
deficiency.  
Purpose: To compare testosterone and vitamin D concentrations in active duty and veteran 
service members between those with and without a history of TBI, and to identify the 
frequency of testosterone prescriptions.  
Materials and Methods: This retrospective de-identified medical review analyzed 
assessments (testosterone, vitamin D) ordered for 4,285 active duty and veteran military 
personnel at Womack Army Medical Center, Fort Bragg, NC from 2016-2018.  
Results: Overall, 343 (8%) of service members had a medically diagnosed TBI. In all men, 
19% were deficient in testosterone (< 270 ng/dl), and 10% had a testosterone prescription. 
Active duty men with a history of TBI had lower testosterone compared to active duty men 
with no documented head injury (431 ± 162 vs 452 ± 170 ng/dl, p = 0.04), but there was no 
significant difference in veteran men. More than one-third (38%) of all service members 
were insufficient in vitamin D (< 30 ng/ml). Overall there was a weak positive correlation 
between testosterone and vitamin D concentrations in men but not in women.   
Conclusions: Our research does not support evidence for high rates of hypogonadism, 
testosterone prescription, or vitamin D deficiency after TBI compared to military personnel 
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without prior injury. However, our overall dataset shows a high prevalence of vitamin D 
insufficiency in both active duty and retired service members independent of TBI, further 
supporting that vitamin D status should be assessed regularly in service members. 
 
Key Phrases: traumatic brain injury; vitamin D; testosterone; testosterone replacement 
therapy; military personnel 
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Introduction 
Traumatic brain injury (TBI) causes long-term consequences including degenerative 
diseases, psychiatric disorders and cognitive, behavioral, and physical defects that may 
prevent military personnel from performing to their greatest potential and negatively impacts 
long-term health.1,2  Neuroendocrine dysfunction is a common consequence of TBI, as nearly 
half of all cases result in symptoms of neuroendocrine dysfunction.3 Neuroendocrine 
dysfunction is the term for a variety of hormone imbalances directly related to the 
hypothalamus, pituitary and their axes.4 Pituitary dysfunction, which manifests in low 
testosterone, is a biochemical deficiency in one or more endocrine axes by either an 
inadequate supply of hypothalamic-releasing hormones or the gland’s inability to produce 
hormones.5 Hypopituitarism with gonadotropin deficiency is one of the most prevalent types 
of neuroendocrine dysfunction following TBI and has been predicted to cause long-term 
secondary hypogonadism in up to 16% of individuals with a TBI diagnosis.6,7 Although not 
normally tested with neuroendocrine disorders, vitamin D deficiency may be associated with 
TBI sequelae. Vitamin D’s neuroprotective role following TBI has been explored in several 
studies, most of which have used an animal model.8–15 It is unclear if TBI causes low vitamin 
D, but if vitamin D is low prior to TBI it may exacerbate injury.8-16 
Numerous studies have shown a decrease in testosterone and vitamin D 
concentrations following TBI in civilians.13,17-27 These studies have investigated mild, 
moderate, and severe TBI in relation to hypopituitarism, testosterone concentrations and 
vitamin D. Studies have shown severe hypopituitarism in all severities of TBI with 
hypogonadism being common, but low testosterone results have varied based on injury 
severity.7 Four studies have investigated testosterone status in military personnel following 
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mild, moderate, and severe blast related TBI. These studies found low testosterone with 
injury with one study finding a significant decrease in testosterone 3 years after injury 
compared to controls.3,28-30 Five civilian studies have investigated vitamin D status post-TBI 
and high rates of vitamin D deficiency were prevalent.13,20,21,23,27 No differences between 
severities were found, with the exception of Toman et al.27 who found the lowest vitamin D 
concentrations in the most severe cases of TBI. 
Research assessing testosterone and vitamin D status in military personnel following 
TBI is lacking, despite the evidence that these hormone deficiencies may exacerbate post-
concussive symptoms. Furthermore, no research to date has examined testosterone 
replacement therapy following TBI. Therefore, the purpose of this study was to compare 
testosterone and vitamin D concentrations between service members with and without a 
history of TBI and to identify rates of testosterone replacement therapy in this sample. 
Incidence of post-TBI hypogonadism and vitamin D deficiency in military personnel helps to 
identify targets for therapeutic treatments to improve long-term recovery. 
Methods 
Study Design & Procedures 
This retrospective de-identified medical review investigated testosterone and vitamin 
D status in active duty and retired service members, with and without a history of traumatic 
brain injury, and the frequency of testosterone replacement therapy prescriptions.  
Study Population 
The study population included 4,285 veteran and active duty service members from 
the United States military who had serum testosterone and vitamin D ordered and assessed at 
Womack Army Medical Center (WAMC), Fort Bragg, NC between October 2016 and 
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December 2018. This protocol was approved by Appalachian State University Institutional 
Review Board and a letter of agreement was established with WAMC. Inclusion criteria was 
current or previous military service, male or female, aged > 18 years, with a serum 
testosterone assessment. Vitamin D was included in analysis if assessed at same time as 
testosterone. Additional data collected from medical records included diagnosis of TBI, 
prescription for testosterone replacement therapy, date of hormonal assessments, and 
participant demographics: age, sex and active duty/veteran military status.  
Data Analysis 
All analyses were conducted with the statistical software package, Stata 15 
(StataCorp 2017). Independent T-tests were used to identify differences between continuous 
variables. Chi Square tests were used to identify differences between dichotomous variables. 
A one-way ANOVA with Bonferroni post hoc analysis was used to test for differences in 
vitamin D across seasons. Statistical significance was p < 0.05. 
Results 
 
Traumatic Brain Injury in Service Members  
From 2016-2018, we identified 4,285 unique cases with testosterone assessments, of 
which 3,204 (75%) of participants were men, and 2,675 (62%) were active duty. Overall, 343 
(8%) of service members and veterans were diagnosed with a TBI between October 2016 and 
September 2018. One hundred and ninety-eight service members had a mild or moderate TBI 
diagnosis, while 143 service members had a TBI of unknown severity. Active duty personnel 
had higher rates of TBI compared to veterans (12 vs. 2%, χ2 (1, N = 4285) = 124, p < 0.01). 
Men were significantly more likely to be diagnosed with a TBI than women (10 vs. 1%, χ2 (1, 
N = 4285) = 93, p < 0.01).  
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Testosterone Concentrations in Service Members 
Overall mean total testosterone concentrations were 427 ± 179 ng/dl (range 5-800 
ng/dl) for men and 31 ± 35 ng/dl (range 5-636 ng/dl) for women (Table 1). Of 3,204 men 
who were assessed, 19% were deficient in testosterone (< 270 ng/dl), and 10% had a 
testosterone prescription. Active duty men without testosterone prescriptions had 
significantly higher testosterone concentrations than active duty men with prescriptions (456 
± 163 vs. 365 ± 225 ng/dl, t = 5, p < 0.001). As expected, active duty men were younger 
with higher testosterone concentrations, lower rates of testosterone deficiency, and lower 
rates of testosterone prescriptions compared to veteran men (Table 1). Women were younger 
with lower testosterone concentrations and lower rates of testosterone prescription than men. 
Of the 1,081 women with testosterone assessments, n = 5 (3 active duty, 2 veteran) had high 
testosterone concentrations (279-636 ng/dl) but did not have testosterone prescriptions. Four 
women (1 active duty, 3 veteran) were prescribed testosterone, with similar formulations as 
those prescribed to male military personnel in this sample. Testosterone prescriptions 
consisted of gels, pellets, patches, and injections of low and high doses (range 2.5-200 mg of 
testosterone). However, the dose prescribed per day is not known.  
In men with a history of TBI, 15% had a testosterone deficiency. However, men 
without TBI were more likely to have testosterone deficiency than men with history of TBI 
(19 vs 15%, χ2 (1, N = 3204) = 4, p < 0.05); and there were no differences in testosterone 
prescriptions between men with and without TBI (7 vs 10%, χ2 (1, N = 3204) = 3, p = 0.068). 
Although total testosterone concentrations in all men (activity duty and veteran) did not 
differ based on TBI history, active duty men with history of TBI had lower testosterone 
compared to active duty men with no documented head injury (Figure 1; 431 ± 162 vs 452 ± 
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170 ng/dl, t = 2, p = 0.035. This difference was not significant in veteran men (Figure 1; 418 
± 138 vs 353 ± 190 ng/dl, t = –2, p = 0.07). When men with testosterone prescriptions were 
excluded from analysis, active duty men with a history of TBI still had lower concentrations 
of testosterone than active duty men without TBI but not at a significant level (440 ± 158 vs 
458 ± 163 ng/dl, t = 2, p = 0.07). There were no significant differences in testosterone 
concentrations in women with and without a history of TBI (28 ± 20 vs 31 ± 35 ng/dl, t = 
0.50, p = 0.66).  
Table 1. Service member’s testosterone, vitamin D, and history of TBI by sex and 
military status. 
 Active Duty  
Men 
(n = 2427) 
Veteran  
Men 
(n = 777) 
Active Duty 
Women 
(n = 248) 
Veteran 
Women 
(n = 833) 
Age (yrs) 37	± 8AC 54 ± 12B 32 ± 8B 33 ± 10 
TBI n = 301 (12%)ABC n = 30 (4%) n = 9 (4%) n = 3 (0.4%) 
Testosterone 
(ng/dl) 
450 ± 169ABC 356 ± 189AB 33 ± 42 30	±	32 
Testosterone 
Deficiency 
(<270 ng/dl) 
n = 340 (14%)C n = 259 (33%)   
Testosterone 
Prescriptions 
n = 169 (7%)ABC n = 155 (20%)AB n = 1 (0.4%) n = 4 (0.5%) 
Vitamin D 
(ng/ml)† 
35 ± 12A 35 ± 11B 33 ± 11 32 ± 12 
Vitamin D 
Insufficiency† 
(<30 ng/ml) 
n = 365 (35%) n = 127 (38%)B n = 39 (45%) n = 127 (47%) 
Data are presented as mean ± standard deviation for continuous variables †Not every subject 
had a vitamin D value (n = 1,742). Ap < 0.05 vs active duty women. Bp < 0.05 vs veteran 
women. Cp < 0.05 vs. veteran men 
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Figure 1. Testosterone concentrations in active duty and veteran men with and without a 
TBI. Data are presented as means ± standard deviation. *p < 0.05 significantly lower than 
active duty males without TBI. 
 
Vitamin D Concentrations in Service Members 
Overall mean vitamin D concentrations were 35 ± 12 ng/ml (range 8-60 ng/ml) for 
men and 32 ± 12 ng/ml (range 9-60 ng/ml) for women. Thirty-eight percent of all service 
members assessed were insufficient in vitamin D (< 30 ng/ml; 36% of men, 46% of women). 
One hundred and fifty-four service members (9%) were deficient in vitamin D (< 20 ng/ml). 
Active duty service members had higher concentrations of vitamin D compared to veterans 
(35 ± 12 vs. 33 ± 12 ng/ml, t = –3, p = < 0.01). Men had higher vitamin D concentrations 
compared to women (35 ± 12 vs. 32 ± 12 ng/ml, t = –4, p = < 0.001). Active duty men had 
higher concentrations of vitamin D compared to active duty women and veteran men had 
higher concentrations of vitamin D compared to veteran women (Table 1). There were no 
significant differences in vitamin D concentrations between active duty and veteran men or 
between active duty and veteran women (Table 1). Veteran women were significantly more 
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likely to have vitamin D insufficiency than veteran men, although there was no difference 
between active duty men and active duty women (Table 1). Season for vitamin D assay was 
evenly distributed: assessments were 24% in the spring, 23% summer, 29% fall, and 24% 
winter. Vitamin D concentrations were significantly different across seasons, hitting a nadir 
in winter and peak in summer (F(3,1738) = 26, p < 0.001; Figure 2). Vitamin D 
concentrations in winter (32 ± 11 ng/ml) were significantly lower than spring (35 ± 12 
ng/ml), summer (38 ± 12 ng/ml) and fall (34 ± 11 ng/ml, p < 0.001). Summer vitamin D 
concentrations were higher than in the spring and fall, but there were no significant 
differences between fall and spring.  
 
Figure 2. Percentage of service members insufficient in vitamin D (< 30 ng/ml) across each 
season: winter (December, January, February), spring (March, April May), summer (June, 
July, August), fall (September, October, November). 
 
Contrary to our hypothesis, service members with a history of TBI had significantly 
higher concentrations of vitamin D compared to service members without a TBI (36 ± 12 vs. 
34 ± 12 ng/ml, t = –2, p < 0.05), but the difference was minimal (2 ng/ml) and of little 
clinical significance. There was no significant difference in service members with and 
without TBI for vitamin D insufficiency (34 vs 38%, χ2 (1, N = 1742) = 1, p = 0.26). Vitamin 
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D concentrations were not different between active duty or veteran service members with or 
without history of TBI (Figure 3). 
 
Figure 3. Vitamin D concentrations in active duty and veteran men (A) and women (B) with 
and without TBI. Data are presented as means ± standard deviation. There were no 
significant differences between groups. 
  
Correlations between Testosterone and Vitamin D Concentrations in Service Members 
Overall, there was a weak positive correlation between testosterone and vitamin D 
concentrations for men (r = 0.099, p < 0.001) but not for women (r = 0.004, p = 0.94). This 
significant correlation was maintained when compared among activity duty men  
(r = 0.087, p = 0.005) and veteran men (r = 0.12, p = 0.028). When men were analyzed 
separately by testosterone prescription, there was still a positive correlation between vitamin 
D and testosterone concentrations for men without testosterone prescriptions  
(r = 0.095, p = 0.003). No significant correlations were found in active duty or veteran 
women.  
There was a weak positive but significant correlation between testosterone and 
vitamin D concentrations (r = 0.099, p < 0.001) for men without a TBI compared to men with 
a TBI (r = 0.11, p = 0.12) Likewise, active duty men without a TBI demonstrated a weak but 
significant positive correlation between testosterone and vitamin D concentrations  
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(r = 0.081, p = 0.018), while active duty men with a history of TBI had no significant 
correlation (r = 0.13, p = 0.076). No significant correlations were found in active duty or 
veteran women with a TBI.  
Discussion 
TBI has been shown to cause low testosterone concentrations due to pituitary 
dysfunction and may have an effect on vitamin D status, but no published research to date 
has investigated both of these hormones in military personnel with TBI. In this retrospective 
analysis of medical records, we did not find higher rates of pituitary dysfunction or vitamin D 
deficiency in military personnel with a history of TBI compared to military personnel 
without prior injury. In our dataset, active duty men with a TBI had statistically lower 
testosterone compared to active duty men without prior injury, but the difference was small 
and of little clinical significance. No clinically meaningful relationship was observed 
between TBI and vitamin D deficiency. However, our overall dataset showed a high 
prevalence of vitamin D insufficiency in both active duty and retired service members 
independent of TBI. Correlations between testosterone and vitamin D concentrations were 
positive but weak in men. Perhaps these findings are driven by a low medically reported TBI 
diagnosis. Eight percent of military personnel in our sample had a TBI diagnosis, which is 
lower than previous research showing 15-23% of military personnel had been diagnosed with 
a TBI.31-35 Our overall findings in military personnel do not support high prevalence of 
hypogonadism in men with history of TBI.   
We found a lower prevalence of pituitary dysfunction (as evidenced by low 
testosterone) in men after TBI compared to previous studies that found 31-47.6% of military 
personnel to have some form of pituitary dysfunction, although not exclusive to 
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hypogonadism. However, our 15% rate of testosterone deficiency after TBI was similar or 
higher than other reported findings, ranging from  0-19%.3,28-30 Contrary to these findings, 
civilian studies investigating pituitary dysfunction after TBI found higher rates of 
hypogonadism among participants (12.5-79%).17-19,22,24-26 These findings suggest that blast-
induced TBI may affect pituitary function differently than non-blast induced TBI, resulting in 
lower rates of hypogonadism.28,30 Time post-injury and clinical cutoffs for testosterone 
deficiency also varied between both military and civilian studies. Nearly all of these studies 
used the 5th or 10th percentile of the sampled group to determine hormone deficiency (134-
350 ng/dl). We used a conservative clinical cut-off of 270 ng/dl, which is used in the military 
medical system. Our results could have also been influenced by the length of time between 
the injury and the testosterone assessment, but our data did not allow for this analysis. 
Gonadotropin function has been shown to spontaneously resolve at 3 to 12 months after 
injury in a majority of patients due to temporary pituitary dysfunction from hypothalamic-
pituitary edema, increased intracranial pressure, and the physiologic response to either 
critical illness or drugs used in the acute phase of TBI.36-38 Our military personnel with TBI 
may have had testosterone deficiency but recovered prior to testosterone assessment and 
treatment, which would explain our low rates of hypogonadism. In addition, a negative 
correlation between testosterone concentrations and injury severity may exist in the 
immediate post-TBI period.37 Perhaps more significant correlations would be evident in 
severe cases.37,38 To our knowledge, this is the first study investigating testosterone 
prescription after TBI. We found no association between testosterone prescriptions and TBI 
diagnosis, which would coincide with the low rates of hypogonadism thus warranting fewer 
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prescriptions. Military treatment facilities have also become more conservative with 
prescribing testosterone replacement therapy.39 
Semistarvation, inadequate sleep, and chronic anxiety during deployment have been 
shown to suppress testosterone levels in military personnel.40,41 This finding may explain 
why active duty men with TBI had lower concentrations of testosterone compared to active 
duty men without injury while veterans with TBI did not have this result. Testosterone 
production may be reduced post-TBI as a result of inflammatory cascade cytokines 
suppressing Leydig cell function in the testes, leading to hypothalamic-pituitary-gonadal axis 
dysfunction.42 Veterans with a TBI had higher testosterone than veterans without a TBI, but 
several veteran men without a TBI in our analysis had very low testosterone (< 10 ng/dl). 
This result is drastically lower than the age-related decline NHANES data has shown with 
participant’s testosterone concentration at age 80 being 30% less than at age 20.43 
Interestingly, none of these testosterone deficient veterans were prescribed testosterone 
replacement therapy; assuming they did not show symptoms of androgen deficiency, this 
finding would be normal according to the Endocrine Society recommendations.44 Another 
explanation for this finding could be influenced by the unknown length of time after injury 
since anterior pituitary trauma may result in normal or high serum concentrations of 
testosterone from the acute release of stored hormones after injury.37  
Our findings on vitamin D concentrations support previous research in civilians and 
military personnel, showing that low vitamin D is a common ailment independent of 
TBI.16,45-50 To our knowledge, this is the first study examining both testosterone and vitamin 
D concentrations in military personnel with and without TBI. Previous studies of civilians 
after TBI found similar rates of vitamin D deficiency compared to our finding (24-47% vs 
 
 27 
34%).20,23,27 However, the cut-off rates for these studies were lower than ours with < 10, 14, 
and 16 ng/ml being deficient. Two studies with an equivalent cut-off found much higher rates 
of deficiency at 63-95%.13,21 Rates of deficiency could be influenced by the difference in 
latitude, clothing, race, and diet of the different countries in which these studies were 
conducted. The 35.1°N latitude of Fort Bragg allows for a long period of endogenous vitamin 
D synthesis, which would explain our lower rate of vitamin D deficiency after TBI.51 
Furthermore, insufficient racial data were available for analysis. Lastly, studies have shown 
mixed results between vitamin D concentrations and TBI severity. Jamall et al.23 found no 
difference in vitamin D among TBI severities, while Toman et al.27 found patients with 
severe TBI were the most deficient in vitamin D. Separate analysis of the most severe TBI 
cases may have shown higher prevalence of low vitamin D, but we did not have severity data 
for all cases.  In this study, the seasonal distribution of vitamin D assessments was fairly 
evenly distributed throughout the year. In the United States, vitamin D seasonality peaks in 
August and nadirs in February, and during winter months UV radiation for most U.S. 
latitudes north of Atlanta, GA (33.7°N) is inadequate for sufficient endogenous synthesis of 
vitamin D.16 
Our weak but positive correlation between vitamin D and testosterone in service men 
is consistent with previous findings by Wentz et al.51, who found a stronger correlation in 
vitamin D deficient men. Contrary to these findings, one study found an increase in 
testosterone concentrations in active duty males during basic military training despite a 
significant decrease in vitamin D. The intense training and anabolic adaptations that occur 
during basic military training may explain the different findings in correlations between 
vitamin D and testosterone.48 Vitamin D may be positively correlated with testosterone levels 
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in males due to the expression of the vitamin D receptor and metabolizing enzymes in the 
Leydig cells of the testes and has been shown to raise testosterone levels in vitamin D 
deficient men.52,53 No correlation was found between vitamin D and testosterone in men with 
TBI possibly due to a lower sample size given that no difference was discovered in vitamin D 
between men with and without injury.  
We did not find evidence that TBI causes low vitamin D, but other research suggests 
that low vitamin D may exacerbate injury. Vitamin D may promote resilience after TBI by 
regulating calcium ions, oxidative stress, inflammation, excitotoxicity and apoptosis during 
the secondary cascade of injury.13,14 Cui et al.10 found that calcitriol treatment can improve 
neurobehavioral defects and cerebral edema in rats after TBI. Progesterone treatment 
combined with vitamin D supplementation after TBI has shown better results in animal 
studies than progesterone alone through maintained spatial and reference memory, 
diminished neuronal loss and astrogliosis, and improved treatment efficacy.8,12,15 Cekic et al.8 
found vitamin D deficient rats had increased baseline brain inflammation and no benefit from 
progesterone treatment compared to vitamin D sufficient rats. In human trials, one clinical 
trial found a combined treatment of progesterone and vitamin D had higher rates of recovery 
than progesterone alone, while another study found vitamin D supplementation 
singlehandedly increased long-term performance and cognitive outcomes  
vitamin D deficient patients with mild-to-moderate TBI. 13,54  
Our overall dataset shows a high prevalence of vitamin D insufficiency. Since 
military personnel are at high risk for TBI and tactical gear limits adequate sunlight 
exposure, it is recommended to assess vitamin D status biannually.55 It would be beneficial to 
supplement those with insufficiency and deficiency accordingly to Endocrine Society 
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Guidelines to maintain optimal vitamin D levels as a preventive measure to improve 
resiliency post-TBI.56 Since gonadotroph function may spontaneously recover in 3 to 12 
months after injury, endocrine evaluation should be completed at 3 to 6 months and re-
assessed at 12 months post-TBI.57,58 
This study was strengthened by a large set of medical records that were reviewed for 
one geographical location, which limited the effect of latitude. Limitations of this study 
include the observational nature of the medical record review in which causal relationships 
cannot be established, only correlations. Furthermore, data for confounding variables such as 
race, sex hormone binding globulin, training status, dietary supplements, length of time after 
injury, and body composition were not available for analysis. Lastly, this sample consists of 
military personnel who had vitamin D and testosterone ordered by a physician and is not 
representative of all service members.  
Our research does not support evidence for high rates of hypogonadism, testosterone 
prescription, or vitamin D deficiency after TBI compared to military personnel without prior 
injury. However, our overall dataset shows a high prevalence of vitamin D insufficiency in 
both active duty and retired service members independent of TBI, further supporting that 
vitamin D status should be assessed regularly in service members. A prospective analysis 
pre-injury may provide better insight into the role of testosterone and vitamin D in TBI. 
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List of Tables 
 
Table 1. Service member’s testosterone, vitamin D, and history of TBI by sex and 
military status. 
 Active Duty  
Men 
(n = 2427) 
Veteran  
Men 
(n = 777) 
Active Duty 
Women 
(n = 248) 
Veteran 
Women 
(n = 833) 
Age (yrs) 37	± 8AC 54 ± 12B 32 ± 8B 33 ± 10 
TBI n = 301 (12%)ABC n = 30 (4%) n = 9 (4%) n = 3 (0.4%) 
Testosterone 
(ng/dl) 
450 ± 169ABC 356 ± 189AB 33 ± 42 30	±	32 
Testosterone 
Deficiency 
(<270 ng/dl) 
n = 340 (14%)C n = 259 (33%)   
Testosterone 
Prescriptions 
n = 169 (7%)ABC n = 155 (20%)AB n = 1 (0.4%) n = 4 (0.5%) 
Vitamin D 
(ng/ml)† 
35 ± 12A 35 ± 11B 33 ± 11 32 ± 12 
Vitamin D 
Insufficiency† 
(<30 ng/ml) 
n = 365 (35%) n =127 (38%)B n = 39 (45%) n = 127 (47%) 
Data are presented as mean ± standard deviation for continuous variables †Not every subject 
had a vitamin D value (n = 1,742). Ap < 0.05 vs active duty women. Bp < 0.05 vs veteran 
women. Cp < 0.05 vs. veteran men 
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Figure 1. Testosterone concentrations in active duty and veteran men with and without a 
TBI. Data are presented as means ± standard deviation. *p < 0.05 significantly lower than 
active duty males without TBI. 
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Figure 2. Percentage of Service Members Insufficient in Vitamin D (< 30 ng/ml) Across 
Each Season: Winter (December, January, February), Spring (March, April May), Summer 
(June, July, August), Fall (September, October, November),  
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Figure 3. Vitamin D concentrations in active duty and veteran men (A) and women (B) with 
and without TBI. Data are presented as means ± standard deviation. There were no 
significant differences between groups 
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